NCT00002504View on ClinicalTrials.gov

Interleukin-2 Plus Interferon Alfa in Treating Adults With Metastatic Cancer

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

August 31, 1992

Primary Completion Date

February 28, 1998

Study Completion Date

February 28, 1999

Conditions
Chronic Myeloproliferative DisordersLeukemiaLymphomaMultiple Myeloma and Plasma Cell NeoplasmMyelodysplastic SyndromesPrecancerous/Nonmalignant ConditionUnspecified Adult Solid Tumor, Protocol Specific
Interventions
BIOLOGICAL

aldesleukin

BIOLOGICAL

recombinant interferon alfa

Trial Locations (5)

37901

Baptist Regional Cancer Center - Knoxville, Knoxville

46260

St. Vincent Hospital and Health Care Center Research Department, Indianapolis

47402

Bloomington Hospital, Bloomington

68124

Bergan Mercy Medical Center, Omaha

92658

Hoag Memorial Hospital Presbyterian, Newport Beach

Sponsors
All Listed Sponsors
collaborator

Cancer Biotherapy Research Group

OTHER

lead

Hoag Memorial Hospital Presbyterian

OTHER

NCT00002504 - Interleukin-2 Plus Interferon Alfa in Treating Adults With Metastatic Cancer | Biotech Hunter | Biotech Hunter